#leukemia — Tuesday, May 19, 2026 (2 items)
| 0 | 💬 0 |
Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-05-19 | #immunotherapy #leukemia #xenograft #adc #myelodysplasia | |
| 0 | 💬 0 |
T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-05-19 | #antibody #immunotherapy #toxicity #leukemia #hematologic |